Prokarium

About:

Prokarium is biopharmaceutical company leading the oncology field of microbial immunotherapy.

Top Investors: Innovate UK, Wellcome Trust, Korea Investment Partners, Biotechnology and Biological Sciences Research Council, Flerie Invest

Description:

Prokarium is a biopharmaceutical company leading the oncology field of microbial immunotherapy The Company’s pipeline is designed to unlock a new generation of immuno-oncology therapeutics by re engineering evolution into a synthetic biology platform Prokarium’s lead program is focused on transforming the treatment paradigm in bladder cancer by orchestrating immune driven, long lasting antitumor effects

Total Funding Amount:

$78.4M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

London, England, United Kingdom

Founded Date:

2012-01-01

Founders:

Rocky Cranenburgh

Number of Employees:

11-50

Last Funding Date:

2023-02-09

IPO Status:

Private

Industries: